Christopher G Pelligra (Christopher Pelligra)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Psychometric Properties

Cardiac Surgery

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Laure Gossec, Ana Maria Orbai, Laura C Coates, Dafna D Gladman, Philip S Helliwell, Christopher G Pelligra, Valérie Ciaravino, Barbara Ink, Vanessa Taieb, Jérémy Lambert, Maarten P T de Wit
Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritis. RMD open 10 (1) (2024)
Laure Gossec, Ana Maria Orbai, Laura C Coates, Dafna D Gladman, Philip S Helliwell, Christopher G Pelligra, Valérie Ciaravino, Barbara Ink, Vanessa Taieb, Jérémy Lambert, Maarten P T de Wit
Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritis. RMD open 10 (1) (2024)
Laure Gossec, Ana Maria Orbai, Laura C Coates, Dafna D Gladman, Philip S Helliwell, Christopher G Pelligra, Valérie Ciaravino, Barbara Ink, Vanessa Taieb, Jérémy Lambert, Maarten P T de Wit
Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritis. RMD open 10 (1) (2024)
Laure Gossec, Ana Maria Orbai, Laura C Coates, Dafna D Gladman, Philip S Helliwell, Christopher G Pelligra, Valérie Ciaravino, Barbara Ink, Vanessa Taieb, Jérémy Lambert, Maarten P T de Wit
Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritis. RMD open 10 (1) (2024)
Ali T Taher, Khaled M Musallam, Vip Viprakasit, Antonis Kattamis, Jennifer Lord-Bessen, Aylin Yucel, Shien Guo, Christopher G Pelligra, Alan L Shields, Jeevan K Shetty, Dimana Miteva, Luciana Moro Bueno, Maria Domenica Cappellini
Psychometric evaluation of the NTDT-PRO questionnaire for assessing symptoms in patients with non-transfusion-dependent beta-thalassaemia. BMJ open 13 (3) (2023)
Ali T Taher, Khaled M Musallam, Vip Viprakasit, Antonis Kattamis, Jennifer Lord-Bessen, Aylin Yucel, Shien Guo, Christopher G Pelligra, Alan L Shields, Jeevan K Shetty, Dimana Miteva, Luciana Moro Bueno, Maria Domenica Cappellini
Psychometric evaluation of the NTDT-PRO questionnaire for assessing symptoms in patients with non-transfusion-dependent beta-thalassaemia. BMJ open 13 (3) (2023)
Lisa J McGarry, Zahra Bhaiwala, Andrea Lopez, Conor Chandler, Christopher G Pelligra, Jaime L Rubin, Theodore G Liou
Calibration and validation of modeled 5-year survival predictions among people with cystic fibrosis treated with the cystic fibrosis transmembrane conductance regulator modulator ivacaftor using United States registry data. PloS one 18 (4) (2023)